Neuropathy Pain Treatment
TECHNOLGY HEALS
Where Technology Heals the Nervous System
What is the NS-100?
The NS-100 is an FDA approved, next-generation medical device developed to reduce neuropathic pain and improve nerve function in individuals with diabetic neuropathy. Using advanced neurostimulation technology, the NS-100 helps restore nerve communication, enhance circulation, and provide relief without dependence on medications
Pain Reduction
Relieves burning, tingling, and numbness in the hands and feet.
Non-Invasive Therapy
Gentle treatment without surgery, injections, or downtime.
Improved Nerve Function
Supports nerve regeneration and healthier circulation.
Drug-Free Relief
Minimizes reliance on pain medications.
Clinically Supported
Backed by research and designed to meet rigorous medical standards.
How It Works
The NS-100 delivers carefully calibrated neurostimulation to affected areas, targeting damaged nerves and helping restore natural signaling. Treatments are comfortable, quick, and can be easily integrated into a patient’s routine.
Who Can Benefit?
The NS-100 is ideal for patients with:
- Diabetic peripheral neuropathy
- Chronic nerve pain in the feet or legs
- Reduced sensation affecting mob and balance
Take back control of your daily life with a safe, effective, and drug-free therapy. The NS-100 helps restore comfort, mobility, and peace of mind.
The NS-100 gives healthcare professionals a reliable, evidence-based solution to address one of the most common and debilitating diabetes complications. Designed for ease of use in clinical or outpatient settings, it enhances patient outcomes while improving satisfaction.
Why Choose the NS-100?
- FDA-cleared medical device (if applicable – confirm)
- Backed by ongoing research and patient success stories
- Designed with patient safety and comfort in mind
- Compact, modern, and easy to use
The NS100
FDA cleared Class II Medical Device offering relief for chronic pain associated with diabetic neuropathy. The NeuroSolutions 100 staff partners with you to support patient care and to create optimal outcomes
- FDA cleared Class II Medical Device
- Proven efficacy in reducing or eliminating chronic pain associated with Diabetic Neuropathy
- Outpatient procedure
- Temporary device worn for 20 days
- Little to no impact on daily activities
- Carrier coverage determined on a case by case basis by NeuroSolutions 100 revenue cycle management team